BIOMAT Database Logo BIOMAT Database Logo

[Hairy cell leukemia: therapeutic strategy]. 1988

G Flandrin, and S Castaigne
Département d'Hématologie clinique, Hôpital Saint-Louis, Paris.

UI MeSH Term Description Entries
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D007943 Leukemia, Hairy Cell A neoplastic disease of the lymphoreticular cells which is considered to be a rare type of chronic leukemia; it is characterized by an insidious onset, splenomegaly, anemia, granulocytopenia, thrombocytopenia, little or no lymphadenopathy, and the presence of "hairy" or "flagellated" cells in the blood and bone marrow. Hairy Cell Leukemia,Leukemic Reticuloendotheliosis,Reticuloendotheliosis, Leukemic,Hairy Cell Leukemias,Leukemias, Hairy Cell,Leukemic Reticuloendothelioses,Reticuloendothelioses, Leukemic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G Flandrin, and S Castaigne
[Hairy cell leukemia: therapeutic approaches].
January 1996, La Revue de medecine interne,
G Flandrin, and S Castaigne
[Therapeutic aspects of hairy cell leukemia].
January 1989, Recenti progressi in medicina,
G Flandrin, and S Castaigne
Therapeutic leukapheresis in hairy cell leukemia.
April 1982, Archives of internal medicine,
G Flandrin, and S Castaigne
[Therapeutic procedure in hairy cell leukemia].
July 1987, Klinische Wochenschrift,
G Flandrin, and S Castaigne
Therapeutic options in hairy-cell leukemia.
December 1985, Seminars in oncology,
G Flandrin, and S Castaigne
Hairy cell leukemia: towards a curative strategy.
October 2006, Hematology/oncology clinics of North America,
G Flandrin, and S Castaigne
Current therapeutic options in hairy cell leukemia.
March 2014, The Journal of community and supportive oncology,
G Flandrin, and S Castaigne
Strategy for the treatment of hairy cell leukemia.
April 1987, Leukemia,
G Flandrin, and S Castaigne
[Therapeutic cytapheresis in hairy cell leukemia and chronic myelocytic leukemia].
October 1982, [Rinsho ketsueki] The Japanese journal of clinical hematology,
G Flandrin, and S Castaigne
Importance of minimal residual disease in hairy cell leukemia: monoclonal antibodies as a therapeutic strategy.
October 2009, Leukemia & lymphoma,
Copied contents to your clipboard!